Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Silexion Therapeutics Corp (NASDAQ: SLXN) closed the day trading at $1.85 down -4.64% from the previous closing price of $1.94. In other words, the price has decreased by -$4.64 from its previous closing price. On the day, 7.18 million shares were traded. SLXN stock price reached its highest trading level at $2.2 during the session, while it also had its lowest trading level at $1.75.
Ratios:
For a better understanding of SLXN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 0.85.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLXN now has a Market Capitalization of 3109998 and an Enterprise Value of 16461319.
Stock Price History:
The Beta on a monthly basis for SLXN is 0.02, which has changed by -0.82395643 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, SLXN has reached a high of $122.02, while it has fallen to a 52-week low of $1.80. The 50-Day Moving Average of the stock is -26.20%, while the 200-Day Moving Average is calculated to be -96.41%.
Shares Statistics:
Over the past 3-months, SLXN traded about 797.77K shares per day on average, while over the past 10 days, SLXN traded about 127960 shares per day. A total of 1.24M shares are outstanding, with a floating share count of 1.02M. Insiders hold about 36.54% of the company’s shares, while institutions hold 8.09% stake in the company. Shares short for SLXN as of 1731628800 were 35842 with a Short Ratio of 0.05, compared to 1728950400 on 9885. Therefore, it implies a Short% of Shares Outstanding of 35842 and a Short% of Float of 3.08.